Petros Pharmaceuticals Inc (PTPI) — Financial Flexibility Index
Petros Pharmaceuticals Inc (PTPI) has a Financial Flexibility Index of -0.05x as of March 2025. Free cash flow of $-1.49 Million (operating CF $-1.49 Million minus capex $0.00) represents 0% of total liabilities ($27.19 Million). Check Petros Pharmaceuticals Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Petros Pharmaceuticals Inc Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Petros Pharmaceuticals Inc across 7 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Petros Pharmaceuticals Inc.
Annual Financial Flexibility Index for Petros Pharmaceuticals Inc (2018–2024)
Year-by-year free cash flow to debt coverage for Petros Pharmaceuticals Inc. Explore PTPI debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.14x | $-2.58 Million | $-2.60 Million | $18.10 Million | ▲ +60.2% |
| 2023 | -0.36x | $-7.63 Million | $-7.63 Million | $21.32 Million | ▲ +56.1% |
| 2022 | -0.81x | $-12.80 Million | $-12.80 Million | $15.72 Million | ▼ -118.6% |
| 2021 | -0.37x | $-11.86 Million | $-11.86 Million | $31.85 Million | ▼ -27.5% |
| 2020 | -0.29x | $-15.30 Million | $-15.31 Million | $52.38 Million | ▼ -664.7% |
| 2019 | 0.05x | $2.60 Million | $2.53 Million | $50.35 Million | ▼ -64.2% |
| 2018 | 0.14x | $9.90 Million | $8.02 Million | $68.57 Million | — |